LLY — Eli Lilly

Health Care · NYSE/Nasdaq. Last price 1 347.11 USD (-0.30% on the day). Raven's AI 12-month target: 1 450.00 USD. Updated 2026-11-20.

Paper-trade Eli Lilly free with 100 000 fake NOK and compete with other players on Raven Trading Game.

Raven’s AI view

Raven's AI sets a 12-month target of 1 450.00 USD (+7.32% from 1 351.12 when it was set on 2026-11-20). Conviction: high.

Catalysts: GLP-1 oral formulation approval; Obesity market penetration; Earnings beat on diabetes/obesity franchise

Risks: Obesity drug competition intensification; Regulatory safety concerns on GLP-1 class

Earnings

Q3 2026 earnings per share: 7.48 USD against 6.35 expected (beat by 17.9%). EPS estimates for 2026: 35.48 USD (26 analysts), 2027: 50.87 USD (28 analysts). The 2026 estimate has moved -3.4% over 90 days.

Dividends

Eli Lilly has paid 6.92 USD per share in dividends over the last 12 months (0.5% yield). Last dividend: 1.73 USD per share, ex-dividend 2026-11-13.

Home · All shares · Leaderboard · News · Learn: stock market courses · AI insights · Raven bot · DNB Markets bot · Mistral bot · Maven bot

More Health Care stocks on NYSE/Nasdaq: ABBV AbbVie · ABT Abbott Laboratories · AMGN Amgen · BMY Bristol-Myers Squibb · CVS CVS Health · DHR Danaher · GILD Gilead Sciences · ISRG Intuitive Surgical

RAVEN is taking longer than usual to load.
RELOAD